PATENT CLAIM ANALYSIS

Application Number: 16230576
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-07
Patent Classification: ["514", "171000"]

Abstract:
A method of promoting remyelination in a subject in need thereof includes administering to the subject a therapeutically effective amount of at least one (1,3) Diazole compound, wherein the therapeutically effective amount is the amount effective to induce endogenous oligodendrocyte precursor cell (OPC) differentiation in the subject's central nervous system.

Claim (Index 37):
The method of  claim 34 , wherein the compound of formula (II) is represented by one of the following formulas: or an analog thereof.

Metadata:
- Claim Count in Document: 54.0
- Percentile: 98.0
- Lexical Diversity: 1.425
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14723008', '15418572', '13985342', '13426364', '14973105']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7967491841367569
- 35 USC 102 Novelty (BERT): 0.585492943042011
- Combined Prediction Score: 0.7756235600272823
- Mean Citation Score: 368.097614
- Max Citation Score: 663.5061599999998
- Similarity Product: 378.0261956048584

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test